Equity Holdings of Nippon India Pharma Fund
Here is the most recent list of
equity holdings in the Nippon India Pharma Fund's portfolio
as of 31 Jan 2024 . The fund's AUM is 8,688.65 crores, of which equity holdings constitute 99.23%.
Name of the Equity | Holding Percentage |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | 13.50% |
LUPIN LTD. | 8.31% |
CIPLA LTD. | 6.08% |
APOLLO HOSPITALS ENTERPRISE LTD. | 5.98% |
DR.REDDY'S LABORATORIES LTD. | 4.89% |
Gland Pharma Ltd | 4.83% |
DIVI'S LABORATORIES LTD. | 4.53% |
AUROBINDO PHARMA LTD. | 3.84% |
Narayana Hrudayalaya Ltd | 3.34% |
Zydus Lifesciences Ltd | 3.31% |
Medplus Health Services Ltd | 3.20% |
AJANTA PHARMA LTD. | 3.05% |
Vijaya Diagnostic Centre Ltd | 3.03% |
Sanofi India Ltd | 2.97% |
ABBOTT INDIA LTD. | 2.87% |
GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 2.79% |
Alkem Laboratories Ltd | 2.74% |
TORRENT PHARMACEUTICALS LTD. | 2.22% |
FORTIS HEALTHCARE LTD. | 2.19% |
PFIZER LTD. | 2.00% |
Thyrocare Technologies Ltd | 1.56% |
Syngene International Ltd | 1.22% |
Orchid Pharma Ltd | 1.05% |
INDOCO REMEDIES LTD. | 0.99% |
Metropolis Healthcare Ltd | 0.49% |
Jubilant Pharmova Ltd | 0.46% |
HealthCare Global Enterprises Ltd | 0.22% |
Tarsons Products Ltd | 0.16% |
ASTRAZENECA PHARMA INDIA LTD. | 0.11% |